PMID- 21305324 OWN - NLM STAT- MEDLINE DCOM- 20110913 LR - 20211020 IS - 1435-5922 (Electronic) IS - 0944-1174 (Linking) VI - 46 IP - 5 DP - 2011 May TI - Nitric oxide induces HIF-1alpha stabilization and expression of intestinal trefoil factor in the damaged rat jejunum and modulates ulcer healing. PG - 565-76 LID - 10.1007/s00535-011-0374-1 [doi] AB - BACKGROUND: The induction of intestinal trefoil factor (ITF) has been reported to depend on hypoxia-inducible factor-1 (HIF-1). Nitric oxide modulates HIF-1 activity. The present study aims to analyze the role of nitric oxide in jejunum damage induced by indomethacin and its ability to modulate epithelial function through the expression of ITF. METHODS: Rats received indomethacin (7.5 mg/kg, s.c., twice), and a time course analysis of damage was performed (24-96 h after the first administration). In these animals, the role of nitric oxide was analyzed by using 1400W, a selective iNOS activity inhibitor (5 mg/kg, i.p./day), on: (1) intestinal damage, (2) ulcer healing, (3) the presence of nitrated proteins in the jejunum and (4) the protein expression of inducible nitric oxide synthase (iNOS), HIF-1alpha and ITF. RESULTS: Indomethacin induced damage in the jejunum that was apparent at 24 h and peaked at 48-72 h. An increase in iNOS, HIF-1alpha, ITF and nitrated proteins was observed in the injured jejunum. Immunoprecipitation of HIF-1alpha allowed determination of the nitration/nitrosylation of this protein by using nitrotyrosine and nitrocysteine antibodies. Blockade of iNOS activity did not significantly modify damage or iNOS expression, but did significantly impede ITF induction, HIF-1alpha stabilization and HIF-1alpha detection with antibodies against nitrated proteins. In parallel to these results, pre-treatment with 1400W delayed the healing of the ulcer provoked by indomethacin. CONCLUSIONS: These results suggest that iNOS-derived NO is involved in HIF-1alpha stabilization, probably through S-nitrosylation, and ITF expression in goblet cells of the damaged jejunum of indomethacin-treated rats and mediates ulcer healing. FAU - Riano, A AU - Riano A AD - Department of Pharmacology and CIBERehd, Faculty of Medicine, University of Valencia, Avda. Blasco Ibanez 15-17, 46010 Valencia, Spain. FAU - Ortiz-Masia, D AU - Ortiz-Masia D FAU - Velazquez, M AU - Velazquez M FAU - Calatayud, S AU - Calatayud S FAU - Esplugues, J V AU - Esplugues JV FAU - Barrachina, Maria Dolores AU - Barrachina MD LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20110209 PL - Japan TA - J Gastroenterol JT - Journal of gastroenterology JID - 9430794 RN - 0 (Anti-Inflammatory Agents, Non-Steroidal) RN - 0 (Hypoxia-Inducible Factor 1, alpha Subunit) RN - 0 (Imines) RN - 0 (N-((3-(aminomethyl)phenyl)methyl)ethanimidamide) RN - 0 (Peptides) RN - 0 (Trefoil Factor-2) RN - 31C4KY9ESH (Nitric Oxide) RN - EC 1.14.13.39 (Nitric Oxide Synthase Type II) RN - XXE1CET956 (Indomethacin) SB - IM MH - Animals MH - Anti-Inflammatory Agents, Non-Steroidal/toxicity MH - Goblet Cells/metabolism MH - Hypoxia-Inducible Factor 1, alpha Subunit/*metabolism MH - Imines/pharmacology MH - Immunoprecipitation MH - Indomethacin/*toxicity MH - Intestinal Mucosa/metabolism MH - Jejunum/drug effects/pathology MH - Male MH - Nitric Oxide/*metabolism MH - Nitric Oxide Synthase Type II/metabolism MH - Peptic Ulcer/chemically induced/pathology MH - Peptides/*metabolism MH - Rats MH - Rats, Sprague-Dawley MH - Time Factors MH - Trefoil Factor-2 EDAT- 2011/02/10 06:00 MHDA- 2011/09/14 06:00 CRDT- 2011/02/10 06:00 PHST- 2010/03/16 00:00 [received] PHST- 2010/12/23 00:00 [accepted] PHST- 2011/02/10 06:00 [entrez] PHST- 2011/02/10 06:00 [pubmed] PHST- 2011/09/14 06:00 [medline] AID - 10.1007/s00535-011-0374-1 [doi] PST - ppublish SO - J Gastroenterol. 2011 May;46(5):565-76. doi: 10.1007/s00535-011-0374-1. Epub 2011 Feb 9.